BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Other News

Momenta autoimmune news

The U.S. Patent and Trademark Office (PTO) awarded Momenta U.S. Patent No. 7,884,187, which claims methods of preparing glatiramer acetate drug product. Momenta and Sandoz International GmbH, the generics unit...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >